Abstract: A pump device according to one embodiment includes a pump and a symbol. The pump includes at least one pump structure and a suction port, wherein a displacement of the at least one pump structure, the displacement being a delivery amount per rotation, changes in accordance with a command current. The symbol is displayed on a surface of the pump, the surface facing in a direction different from a direction in which the suction port is open. The symbol stores actual measurement data or save location information on the actual measurement data, the actual measurement data indicating an actual relationship between the command current and the displacement of the at least one pump structure.

Abstract: A hydraulic pump performance deterioration detection system according to one embodiment includes: a hydraulic pump that is driven by a prime mover and that supplies a hydraulic liquid to a hydraulic actuator to move the hydraulic actuator; a switching valve located on a passage through which the hydraulic liquid delivered from the hydraulic pump flows, the switching valve being switchable between an open position and a closed position; and control circuitry configured to change a rotation speed of the prime mover. When the hydraulic actuator is not moving, in a state where the switching valve is switched to the closed position, the control circuitry determines whether or not performance of the hydraulic pump has deteriorated based on the rotation speed of the prime mover and a delivery pressure of the hydraulic pump measured by a pressure sensor.

Abstract: A hydraulic pump performance deterioration detection system according to one embodiment includes: a variable displacement hydraulic pump that supplies a hydraulic liquid to a hydraulic actuator to move the hydraulic actuator; a regulator that changes a displacement of the hydraulic pump in accordance with a command current; and control circuitry that feeds the command current to the regulator. When the hydraulic actuator is not moving, in a state where a switching valve located on a passage through which the hydraulic liquid delivered from the hydraulic pump flows is switched to a closed position and the hydraulic pump is being driven at a predetermined rotation speed, the control circuitry determines whether or not performance of the hydraulic pump has deteriorated based on a current value of the command current and a delivery pressure of the hydraulic pump measured by a pressure sensor.

Abstract: A viscosity modifier is thermally stable and can provide an excellent viscosity-increasing effect and/or an anti-sagging effect, and is used by the addition to a paint, a coating agent, a painting agent, a flux, an adhesive material, and a sealing material that are produced/used under high temperature conditions. A film-forming agent contains the viscosity modifier including a polyamide component that contains a polyamide compound from a C2-10 aliphatic and/or C6-10 aromatic primary diamine and a C12-36 polybasic acid and/or a C12-30 unsubstituted or hydroxy-substituted aliphatic monocarboxylic acid. The film-forming agent contains the viscosity modifier and a film-forming component and is at least any one selected from a paint, a coating material, a painting material, a flux, an adhesive material, and a sealing material.

Abstract: Provided is an antifoaming agent for a coating agent, which suppresses foaming of a coating agent by being blended into a nonaqueous agent in a small amount, thereby improving pinhole preventing performance, and which may form a thermo-setting coating film or a thermo-drying coating film having an excellent aesthetic appearance by suppressing the generation of pinholes without deteriorating smoothing performance of the coating film even under conditions where pinholes are easily generated.

Abstract: A pancreatic endocrine cell indicating agent of the present invention includes a modified polypeptide in which a metal chelator binds only to an amino acid that is located at a site other than a somatostatin receptor-binding active site in a polypeptide selected from the group consisting of somatostatin and somatostatin analogs; and a radioactive metal nuclide held by the metal chelator. According to the present invention, it is therefore possible to provide a novel pancreatic endocrine cell indicating agent.